Esophageal Cancer Radiotherapy Dose Escalation Meta Regression Commentary: "High . Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis"

Overview

Journal Front Oncol

Specialty Oncology

Date 2021 Aug 2

PMID 34336689

Citations 1

Authors

Ronald Chow

Michael Lock

Sangjune Laurence Lee

Simon S Lo

Charles B Simone 2nd

Affiliations

Soon will be listed here.

Citing Articles

Analysis of the prognostic factors of simultaneous integrated boost-intensity modulated radiation therapy (SIB-IMRT) in 220 cases of locally advanced squamous esophageal cancer: a retrospective cohort study.

Zhou S, Yang Y, Zhang Q, Zhu C, Cai P, Li D Ann Transl Med. 2023; 11(2):103.

PMID: 36819557 PMC: 9929776. DOI: 10.21037/atm-22-6462.

References

Clavier J, Antoni D, Atlani D, Ben Abdelghani M, Schumacher C, Salze P . [Definitive chemoradiotherapy for esophageal cancer: 66Gy versus 50Gy, a retrospective study]. Cancer Radiother. 2013; 17(3):221-8. DOI: 10.1016/j.canrad.2013.01.017. View

Zhu W, Zhou K, Yu C, Han J, Li T, Chen X . Efficacy analysis of simplified intensity-modulated radiotherapy with high or conventional dose and concurrent chemotherapy for patients with neck and upper thoracic esophageal carcinoma. Asian Pac J Cancer Prev. 2012; 13(3):803-7. DOI: 10.7314/apjcp.2012.13.3.803. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Lee S, Bassetti M, Meijer G, Mook S . Review of MR-Guided Radiotherapy for Esophageal Cancer. Front Oncol. 2021; 11:628009. PMC: 8019940. DOI: 10.3389/fonc.2021.628009. View

Chen C, Li C, Chien C . Does higher radiation dose lead to better outcome for non-operated localized esophageal squamous cell carcinoma patients who received concurrent chemoradiotherapy? A population based propensity-score matched analysis. Radiother Oncol. 2016; 120(1):136-9. DOI: 10.1016/j.radonc.2016.04.042. View

Brower J, Chen S, Bassetti M, Yu M, Harari P, Ritter M . Radiation Dose Escalation in Esophageal Cancer Revisited: A Contemporary Analysis of the National Cancer Data Base, 2004 to 2012. Int J Radiat Oncol Biol Phys. 2016; 96(5):985-993. DOI: 10.1016/j.ijrobp.2016.08.016. View

Minsky B, Pajak T, Ginsberg R, Pisansky T, Martenson J, Komaki R . INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002; 20(5):1167-74. DOI: 10.1200/JCO.2002.20.5.1167. View

Yen Y, Chang J, Lin W, Chiou J, Chang Y, Chang C . Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques. Cancer. 2017; 123(11):2043-2053. DOI: 10.1002/cncr.30565. View

Chang C, Tsai H, Lin W, Chang J, Hsu H, Chow J . Dose escalation intensity-modulated radiotherapy-based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma. Radiother Oncol. 2017; 125(1):73-79. DOI: 10.1016/j.radonc.2017.08.025. View

10.

Zhang W, Luo Y, Wang X, Han G, Wang P, Yuan W . Dose-escalated radiotherapy improved survival for esophageal cancer patients with a clinical complete response after standard-dose radiotherapy with concurrent chemotherapy. Cancer Manag Res. 2018; 10:2675-2682. PMC: 6097517. DOI: 10.2147/CMAR.S160909. View

11.

Ren X, Wang L, Han C, Ren L . Retrospective analysis of safety profile of high-dose concurrent chemoradiotherapy for patients with oesophageal squamous cell carcinoma. Radiother Oncol. 2018; 129(2):293-299. DOI: 10.1016/j.radonc.2018.09.006. View

12.

Simone 2nd C . First Randomized Trial Supporting the Use of Proton Over Photon Chemoradiotherapy in Esophageal Cancer. J Clin Oncol. 2020; 38(26):2952-2955. DOI: 10.1200/JCO.20.01405. View

13.

He L, Allen P, Potter A, Wang J, Chang J, Gomez D . Re-evaluating the optimal radiation dose for definitive chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Oncol. 2014; 9(9):1398-405. DOI: 10.1097/JTO.0000000000000267. View

14.

Ke T, Fong Y, Lin L, Chien Y, Yang C, Lin C . Evaluating the optimal radiation dose for definitive chemoradiotherapy for esophageal squamous cell carcinoma: A single institution experience. Medicine (Baltimore). 2018; 97(46):e13214. PMC: 6257338. DOI: 10.1097/MD.0000000000013214. View

15.

Sun X, Wang L, Wang Y, Kang J, Jiang W, Men Y . High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis. Front Oncol. 2020; 10:1222. PMC: 7418493. DOI: 10.3389/fonc.2020.01222. View

16.

Kim H, Suh Y, Lee Y, Lee S, Shin S, Cho B . Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy. Cancer Res Treat. 2016; 49(3):669-677. PMC: 5512369. DOI: 10.4143/crt.2016.354. View

17.

Zhu H, Rivin Del Campo E, Ye J, Simone 2nd C, Zhu Z, Zhao W . Involved-Field Irradiation in Definitive Chemoradiotherapy for Locoregional Esophageal Squamous Cell Carcinoma: Results From the ESO-Shanghai 1 Trial. Int J Radiat Oncol Biol Phys. 2021; 110(5):1396-1406. DOI: 10.1016/j.ijrobp.2021.02.053. View

18.

Deng Y, Bian C, Tao H, Zhang H . Improved survival with higher radiation dose for esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy. Oncotarget. 2017; 8(45):79662-79669. PMC: 5668079. DOI: 10.18632/oncotarget.19030. View

19.

Cooper J, Guo M, Herskovic A, Macdonald J, Martenson Jr J, Al-Sarraf M . Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA. 1999; 281(17):1623-7. DOI: 10.1001/jama.281.17.1623. View

20.

Li C, Fang H, Lin C, Shen W, Chien C . Outcomes of Localized Esophageal Squamous Cell Carcinoma Patients Treated With Definitive Concurrent Chemoradiotherapy Using Either Standard or High Radiotherapy Dose: A Retrospective Study Controlling for Organ at Risk Dose. Anticancer Res. 2018; 39(1):511-517. DOI: 10.21873/anticanres.13142. View